Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. by Bots, M.L. (Michiel) et al.
ISSN: 1524-4539 
Copyright © 2004 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online
72514
Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX
DOI: 10.1161/01.CIR.0000120708.59903.1B 
 2004;109;1089-1094; originally published online Mar 1, 2004; Circulation
Deirdre A.M. van der Kuip and Jacqueline C.M. Witteman 
Irene M. van der Meer, Michiel L. Bots, Albert Hofman, Antonio Iglesias del Sol,
 Myocardial Infarction: The Rotterdam Study
Predictive Value of Noninvasive Measures of Atherosclerosis for Incident
 http://circ.ahajournals.org/cgi/content/full/109/9/1089
located on the World Wide Web at: 
The online version of this article, along with updated information and services, is
 http://www.lww.com/static/html/reprints.html
Reprints: Information about reprints can be found online at 
  
 journalpermissions@lww.com
Street, Baltimore, MD 21202-2436. Phone 410-5280-4050. Fax: 410-528-8550. Email: 
Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, 351 West Camden
  
 http://circ.ahajournals.org/subsriptions/
Subscriptions: Information about subscribing to Circulation is online at 
 at SWETS SUBS SERVICE on November 7, 2006 circ.ahajournals.orgDownloaded from 
Predictive Value of Noninvasive Measures of Atherosclerosis
for Incident Myocardial Infarction
The Rotterdam Study
Irene M. van der Meer, MD, PhD; Michiel L. Bots, MD, PhD;
Albert Hofman, MD, PhD; Antonio Iglesias del Sol, MD, PhD;
Deirdre A.M. van der Kuip, MD, PhD; Jacqueline C.M. Witteman, PhD
Background—Several noninvasive methods are available to investigate the severity of extracoronary atherosclerotic
disease. No population-based study has yet examined whether differences exist between these measures with regard to
their predictive value for myocardial infarction (MI) or whether a given measure of atherosclerosis has predictive value
independently of the other measures.
Methods and Results—At the baseline (1990–1993) examination of the Rotterdam Study, a population-based cohort study
among subjects age 55 years, carotid plaques and intima-media thickness (IMT) were measured by ultrasound,
abdominal aortic atherosclerosis by x-ray, and lower-extremity atherosclerosis by computation of the ankle-arm index.
In the present study, 6389 subjects were included; 258 cases of incident MI occurred before January 1, 2000. All 4
measures of atherosclerosis were good predictors of MI independently of traditional cardiovascular risk factors. Hazard
ratios were equally high for carotid plaques (1.83 [1.27 to 2.62], severe versus no atherosclerosis), carotid IMT (1.95
[1.19 to 3.19]), and aortic atherosclerosis (1.94 [1.30 to 2.90]) and slightly lower for lower-extremity atherosclerosis
(1.59 [1.05 to 2.39]), although differences were small. The hazard ratio for MI for subjects with severe atherosclerosis
according to a composite atherosclerosis score was 2.77 (1.70 to 4.52) compared with subjects with no atherosclerosis.
The predictive value of MI for a given measure of atherosclerosis was independent of the other atherosclerosis measures.
Conclusions—Noninvasive measures of extracoronary atherosclerosis are strong predictors of MI. The relatively crude
measures directly assessing plaques in the carotid artery and abdominal aorta predict MI equally well as the more
precisely measured carotid IMT. (Circulation. 2004;109:1089-1094.)
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Various noninvasive methods are available to detect thepresence and severity of extracoronary atherosclerotic
disease. Carotid atherosclerosis as shown on ultrasound,
aortic atherosclerosis on abdominal x-ray, and lower-
extremity atherosclerosis reflected by the ankle-arm index
(AAI) are validated measures of atherosclerosis that are
routinely used in population-based studies because they
are relatively cheap, noninvasive, and easy to assess. They are
strongly associated with the presence and amount of coronary
calcification1 and with traditional cardiovascular risk
factors.2–4
Several studies have shown that these measures of athero-
sclerosis are good predictors of coronary heart disease
(CHD).5–12 However, differences between measures with
regard to their predictive value for CHD may exist, because
of either factors related to the site at which atherosclerosis
was measured or factors associated with the measurement
method. No population-based study has yet compared the
predictive value of several different measures of atheroscle-
rosis or investigated whether the information provided by a
given measure of atherosclerosis is independent of that
provided by other atherosclerosis measures.
Within the Rotterdam Study, a population-based cohort
study among men and women age 55 years and over, we
prospectively investigated several noninvasive measures of
extracoronary atherosclerosis and combinations of these mea-




The Rotterdam Study is a prospective population-based cohort study
of 7983 men and women age 55 years. Its overall aim is to
investigate the incidence and determinants of chronic disabling
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diseases. From 1990 to 1993, all inhabitants of a suburb of the city
of Rotterdam age 55 years were invited to participate in the study.
The overall response rate was 78%. A trained investigator visited all
participants at home and collected information using a computerized
questionnaire. The information obtained included current health
status, medical history, drug use, and smoking behavior. In addition,
during 2 visits to the research center, established cardiovascular risk
factors were measured. The Medical Ethics Committee of the
Erasmus University Medical Center approved the Rotterdam Study,
and written informed consent was obtained from all participants. A
more detailed description of the Rotterdam Study and the collection
of data has been given elsewhere.13,14
Study Population
Of the 7983 participants of the Rotterdam Study, 7393 had never
experienced an MI or revascularization procedure before the baseline
examination. For 6525 participants, the extent of atherosclerosis was
assessed at at least 1 site of the vascular tree, and follow-up data on
incident MI were available for 6442 of these participants. Subjects
with missing data on more than 2 of the established cardiovascular
risk factors were excluded (n53), resulting in a study population of
6389 participants.
Measures of Atherosclerosis
Each of the measures of atherosclerosis included in the present study
was categorized into no, mild, moderate, and severe atherosclerosis.
To be able to compare the associations of the different measures of
atherosclerosis with incident MI, we aimed at categorizing the
severity of atherosclerosis in such a way that especially the severe
category included a comparable percentage of the population for all
of the 4 measures.
Carotid Atherosclerosis
By use of ultrasound, the common carotid artery, carotid bifurcation,
and internal carotid artery were visualized over a length as large as
possible and examined both left and right for the presence of plaques,
which were defined as focal widenings relative to adjacent segments,
with protrusion into the lumen, composed of calcified or noncalcified
components. Those assessing the presence of plaques were blinded
to all clinical information. Within the Rotterdam Study, a reproduc-
ibility study for plaques in the carotid artery on either side resulted
in a  of 0.67, indicating moderate agreement. A weighted plaque
score ranging from 0 to 6 was computed by adding the number of
sites at which a plaque was detected, divided by the total number of
sites for which an ultrasonographic image was available and multi-
plied by 6 (the maximum number of sites).15 Subjects for whom data
on the presence of plaques were not available for at least 2 of the 6
sites that were examined were excluded. Subjects with a carotid
plaque score of 0, 1, 2, and 3 points were considered to have no,
mild, moderate, and severe carotid atherosclerosis, respectively.
The maximum common carotid intima-media thickness (IMT)
was determined as the average of the maximum IMT of near- and
far-wall measurements over a length of 1 cm, and the average of left
and right maximum common carotid IMT was computed. In a
reproducibility study, intraclass correlation coefficients between
ultrasonographers, readers, and visits to the study center were 0.63,
0.88, and 0.74, respectively.16 To indicate no, mild, moderate, and
severe thickening of the carotid wall, we divided the IMT into
quartiles based on the population distribution, using cutoff points of
0.88, 0.99, and 1.12 mm, respectively. Because of limited availabil-
ity of ultrasonographers at the end of 1992 and in 1993, ultrasound
data on carotid atherosclerosis are missing for part of the study
population.
Aortic Atherosclerosis
Aortic atherosclerosis was diagnosed by radiographic detection of
calcified deposits in the abdominal aorta on a lateral abdominal film.
In an autopsy study, radiographic assessment was shown to be highly
specific, and in most cases visible calcification represented advanced
intimal atherosclerosis.17 A comparison study at our department
among 56 subjects involving CT showed that abdominal calcifica-
tion could be detected radiographically in 32 subjects; in all but 1 of
these subjects, calcification was located in the aorta on the corre-
sponding CT images.3 The extent of abdominal aortic atherosclerosis
was scored according to the length of the involved area (with scores
of 0 to 5 corresponding to 0, 1, 1 to 2.5, 2.5 to 4.9, 5.0 to 9.9, and
10.0 cm, respectively). Subjects with an aortic atherosclerosis
score of 0, 1, 2, and 3 points were considered to have no, mild,
moderate, and severe aortic atherosclerosis, respectively.
Lower-Extremity Atherosclerosis
We obtained the AAI as described before by computing the ratio of
the systolic blood pressure at the ankle to the systolic blood pressure
at the arm, a method that has been shown to provide reliable
measurements of lower-extremity atherosclerosis.14,18 The AAI is
inversely related to the severity of lower-extremity atherosclerosis.
For the analyses, we used the lowest value of 2 legs. Because arterial
rigidity prevents arterial compression and will therefore lead to
spurious high values of the AAI, an AAI 1.50 was considered
invalid. To indicate no, mild, moderate, and severe lower-extremity
atherosclerosis, we divided the AAI into quartiles based on the
population distribution, using cutoff points of 1.21, 1.10, and 0.97,
respectively.
Atherosclerosis Score
To compute a composite atherosclerosis score, we added 0, 1, 2, and
3 points to the score for a subject being in the no, mild, moderate,
and severe category, respectively, for each of the 4 separate
measures, thus creating a score ranging from 0 to 12 points. For
subjects with complete data on 3 of the 4 measures of atherosclero-
sis, we computed a weighted atherosclerosis score by multiplying the
score obtained for 3 measures by 4/3. The mean composite athero-
sclerosis score was 6.0 for men and 5.6 for women. To indicate no,
mild, moderate, and severe atherosclerosis, we subsequently divided
the composite score into quartiles based on the population distribu-
tion, using cutoff points of 4, 6, and 9, respectively.
Data on carotid plaques, carotid IMT, aortic atherosclerosis,
lower-extremity atherosclerosis, and the composite atherosclerosis
score were available for 5070, 5116, 5234, 5838, and 5197 subjects,
respectively.
Follow-Up Procedures
Follow-up started at the baseline examination and for the present
study lasted until January 1, 2000. Of all participants in the present
study, 168 (2.6%) were lost to follow-up. For these subjects, the
follow-up time was computed until the last date of contact. Fatal and
nonfatal cardiovascular events were reported by general practitioners
in the research district, with whom 85% of the participants of the
Rotterdam Study were enlisted. Research assistants verified all
information by checking medical records at the general practitioners’
offices. All medical records of the participants under the care of
general practitioners outside the study area were checked annually
for possible events. Letters and, in case of hospitalization, discharge
reports from medical specialists were obtained. With respect to the
vital status of participants, information was also obtained regularly
from the municipal health authorities in Rotterdam. After notifica-
tion, cause and circumstances of death were established by question-
naire from the general practitioners. Two research physicians inde-
pendently coded all reported events according to the International
Classification of Diseases, 10th edition (ICD-10).19 Codes on which
the research physicians disagreed were discussed to reach consensus.
Finally, a medical expert in cardiovascular disease, whose judgment
was considered final, reviewed all events. Incident MI was defined as
the occurrence of a fatal or nonfatal MI (ICD-10 code I21) after the
baseline examination.
Statistical Analyses
For subjects with missing data on clinical characteristics measured
on a continuous scale, we imputed the population mean (n308 with
missing data on at most 2 characteristics). For subjects with missing
data on smoking habits (n128) or diabetes mellitus (n30), we
made use of a missing variable indicator. Proportional hazards
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regression analysis was used to evaluate the predictive value for MI
of categories of the individual measures of atherosclerosis and of the
composite atherosclerosis score, taking only age and gender into
account (model 1), or also smoking habits, body mass index, total
and HDL cholesterol, systolic and diastolic blood pressure, presence
of diabetes mellitus, and use of aspirin, blood pressure–lowering, and
cholesterol-lowering medication (model 2). Subsequently, to inves-
tigate whether a given measure of atherosclerosis predicts MI
independently of the other measures, we included each possible
combination of 2 measures of atherosclerosis in the fully adjusted
model. Finally, for each combination of 2 measures of atherosclero-
sis, we divided the population into 9 groups based on the 9 possible
combinations of no, mild/moderate (as 1 category), and severe
atherosclerosis as categorized per measure. To compute hazard ratios
for MI, we used the group with subjects who were for both measures
in the category of no atherosclerosis as the referent group. All
analyses were performed using SPSS 9.0 for Windows.
Results
Baseline characteristics of the total study population are
shown in Table 1. The distribution of no, mild, moderate, and
severe carotid plaques was 42.2%, 15.3%, 18.4%, and 24.0%,
respectively. For aortic atherosclerosis, these numbers were
34.7%, 9.6%, 26.5%, and 29.2%.
During follow-up, incident MI occurred in 258 subjects
(4.0%; 143 men and 115 women). Tables 2 and 3 show that
all measures of atherosclerosis were strongly predictive of
incident MI, even after adjustment for a wide range of
cardiovascular risk factors and medication use (model 2).
When analyzed as continuous variables, the multivariate
hazard ratios for MI associated with 1 SD increase in carotid
IMT and 1 SD decrease in the AAI were 1.28 (1.14 to 1.44)
and 1.20 (1.05 to 1.39), respectively, in a fully adjusted model
(model 2). Of the 4 individual measures, the hazard ratios
were equally high for carotid plaques (1.83 [1.27 to 2.62] for
the severe category, model 2), carotid IMT (1.95 [1.19 to
3.19]), and aortic atherosclerosis (1.94 [1.30 to 2.90]). Hazard
ratios were slightly lower for lower-extremity atherosclerosis
(1.59 [1.05 to 2.39]), although differences were very small.
The multivariately adjusted hazard ratios for peripheral arte-





Gender, % women 61.9
Current smokers, % 21.5
Body mass index, kg/m2 26.33.7
Total cholesterol, mmol/L 6.61.2
HDL cholesterol, mmol/L 1.40.4
Systolic blood pressure, mm Hg 139.622.3
Diastolic blood pressure, mm Hg 73.911.6
Diabetes mellitus, % 10.1
Cholesterol-lowering medication, % 1.6
Blood pressure–lowering medication, % 29.4
Aspirin, % 8.7
Carotid plaques, %* 57.8
Intima-media thickness, mm 1.020.21
Aortic atherosclerosis, %† 65.3
Ankle-arm index‡ 1.050.23
Composite atherosclerosis score§ 5.83.3
Data are meanSD for continuous variables and percentages for dichoto-
mous variables.
*As indicated by a carotid plaque score 0.
†As indicated by an aortic atherosclerosis score 0.
‡Lowest of left and right leg.
§With a range of 0 to 12 points.
TABLE 2. Hazard Ratios for Incident Myocardial Infarction Associated With Carotid Measures
of Atherosclerosis
Severity of Atherosclerosis
No Mild Moderate Severe
Carotid plaques
Model 1 1.0 1.33 (0.84–2.09) 1.49 (0.99–2.24) 2.45 (1.72–3.47)
Model 2 1.0 1.19 (0.75–1.88) 1.28 (0.85–1.94) 1.83 (1.27–2.62)
 Carotid intima-media thickness 1.0 1.19 (0.75–1.89) 1.24 (0.81–1.88) 1.74 (1.19–2.56)
 Aortic atherosclerosis 1.0 1.18 (0.74–1.88) 1.06 (0.68–1.65) 1.49 (1.01–2.21)
 Lower-extremity atherosclerosis 1.0 1.20 (0.76–1.92) 1.22 (0.80–1.88) 1.82 (1.25–2.65)
Carotid intima-media thickness
Model 1 1.0 1.68 (1.03–2.75) 2.05 (1.26–3.32) 2.91 (1.80–4.70)
Model 2 1.0 1.56 (0.95–2.54) 1.63 (1.00–2.65) 1.95 (1.19–3.19)
 Carotid plaques 1.0 1.56 (0.94–2.57) 1.49 (0.90–2.46) 1.70 (1.01–2.85)
 Aortic atherosclerosis 1.0 1.53 (0.92–2.57) 1.52 (0.91–2.55) 1.79 (1.06–3.01)
 Lower-extremity atherosclerosis 1.0 1.64 (1.00–2.70) 1.59 (0.96–2.64) 1.94 (1.17–3.23)
The no, mild, moderate, and severe categories included 2140, 778, 935, and 1217 subjects for carotid plaques and
1277, 1279, 1287, and 1273 subjects for carotid intima-media thickness. All hazard rate ratios were adjusted for age
and gender (model 1), and subsequently (model 2) for smoking habits, body mass index, total and HDL cholesterol,
systolic and diastolic blood pressure, presence of diabetes mellitus, and use of aspirin, blood pressure–lowering, and
cholesterol-lowering medication. Model 2 was additionally adjusted for severity of atherosclerosis as indicated by the
various atherosclerosis measures, added to the model individually.
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rial disease as defined by an AAI 0.9 or 0.8 were 1.11
(0.81 to 1.54) and 1.12 (0.76 to 1.64), respectively.
Hazard ratios were highest for the composite atherosclero-
sis score (Table 3). In subgroup analyses stratified by gender,
the multivariately adjusted risk estimates for the mild, mod-
erate, and severe categories of the composite atherosclerosis
score compared with no atherosclerosis were 1.30 (0.71 to
2.38), 1.14 (0.62 to 2.10), and 2.24 (1.22 to 4.11), respec-
tively, for men and 1.15 (0.46 to 2.89), 2.98 (1.35 to 6.59),
and 3.80 (1.64 to 8.79), respectively, for women. For each of
the 4 separate measures of atherosclerosis, hazard ratios also
tended to be higher for women than for men, especially in the
severe categories (data not shown). The survival curves for
different categories of the composite atherosclerosis score are
shown in Figure 1.
When we simultaneously included 2 measures of athero-
sclerosis in the model, the hazard ratios for these measures
were not meaningfully different from those obtained from
fully adjusted models in which only 1 atherosclerosis mea-
sure was included, indicating independence of effect (Tables
2 and 3). Figure 2 clearly shows that for combinations of
measures of atherosclerosis, categorization according to an
extra measure of atherosclerosis adds prognostic information
with regard to the occurrence of MI to categorization accord-
ing to a single atherosclerosis measure.
Discussion
The results of the present study show that measures of
atherosclerosis assessing the severity of carotid plaques,
carotid IMT, aortic atherosclerosis, or lower-extremity ath-
erosclerosis are all strong predictors of incident MI. Although
differences were small, risk estimates for lower-extremity
atherosclerosis were slightly weaker than those for measures
of carotid or aortic atherosclerosis.
Carotid atherosclerosis as shown on ultrasound, aortic
atherosclerosis on abdominal x-ray, and lower-extremity
atherosclerosis reflected by the AAI are all strongly associ-
ated with the presence and amount of coronary calcification,1
traditional cardiovascular risk factors,2–4 and the incidence of
CHD.5–12,20 Compared with carotid IMT and the AAI, the
presence and severity of carotid plaques or aortic atheroscle-
rosis are less frequently studied in relation to cardiovascular
disease. Importantly, the present study shows that the hazard
ratios for MI for these measures, which are based on the
relatively crude but direct assessment of the presence of
atherosclerotic plaques, were as high as those for carotid
IMT, a measure that requires very precise measurements.
TABLE 3. Hazard Ratios for Incident Myocardial Infarction Associated With Aortic and
Lower-Extremity Atherosclerosis and With the Composite Atherosclerosis Score
Severity of Atherosclerosis
No Mild Moderate Severe
Aortic atherosclerosis
Model 1 1.0 1.16 (0.62–2.17) 2.13 (1.43–3.18) 2.56 (1.73–3.78)
Model 2 1.0 1.06 (0.56–1.98) 1.81 (1.21–2.70) 1.94 (1.30–2.90)
 Carotid plaques 1.0 0.92 (0.45–1.87) 1.84 (1.20–2.83) 1.64 (1.05–2.57)
 Carotid intima-media thickness 1.0 1.02 (0.52–2.03) 1.84 (1.20–2.83) 1.80 (1.16–2.78)
 Lower-extremity atherosclerosis 1.0 0.85 (0.42–1.72) 1.83 (1.21–2.76) 1.93 (1.27–2.91)
Lower-extremity atherosclerosis
Model 1 1.0 1.25 (0.82–1.89) 1.89 (1.28–2.78) 2.19 (1.48–3.23)
Model 2 1.0 1.12 (0.74–1.70) 1.55 (1.04–2.31) 1.59 (1.05–2.39)
 Carotid plaques 1.0 1.20 (0.75–1.91) 1.61 (1.03–2.53) 1.54 (0.97–2.45)
 Carotid intima-media thickness 1.0 1.20 (0.76–1.90) 1.62 (1.04–2.53) 1.59 (1.01–2.50)
 Aortic atherosclerosis 1.0 1.02 (0.65–1.59) 1.39 (0.90–2.14) 1.51 (0.97–2.34)
Composite atherosclerosis score
Model 1 1.0 1.52 (0.92–2.51) 2.28 (1.43–3.62) 4.35 (2.75–6.86)
Model 2 1.0 1.28 (0.77–2.12) 1.71 (1.06–2.76) 2.77 (1.70–4.52)
See legend to Table 2. The no, mild, moderate, and severe categories included 1818, 502, 1388, and 1526 subjects
for aortic atherosclerosis; 1415, 1471, 1448, and 1504 subjects for lower-extremity atherosclerosis; and 1499, 1151,
1349, and 1198 subjects for the composite atherosclerosis score.
Figure 1. Survival curves for no, mild, moderate, and severe
atherosclerosis as indicated by the composite atherosclerosis
score. Analyses were adjusted for age and gender.
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The predictive value for MI of each of the individual
measures of atherosclerosis was independent of a wide
variety of traditional cardiovascular risk factors and of
medication use. For purposes of MI risk stratification, the
measurement of extracoronary atherosclerotic disease as an
indication of the presence of unknown or unmeasured car-
diovascular risk factors, such as genetic predisposition or
inflammation,21,22 may therefore be a meaningful addition to
the measurement of traditional cardiovascular risk factors.
Although the measurement of carotid IMT is unlikely to be of
use as a screening tool in the general population,23 measure-
ment of the AAI has been suggested to be useful in persons
50 years old or persons at high risk.24 However, the hazard
ratios for MI associated with lower-extremity atherosclerosis
were slightly lower in the present study than those associated
with the other measures of atherosclerosis, which may be
explained by the fact that the AAI is an indirect measure of
lower-extremity atherosclerosis, which may also be influ-
enced by hemodynamic factors and vascular stiffness. Future
research, which should also include a measure of coronary
calcium, is needed to establish the clinical value of the
various measures of atherosclerosis either in the general
population or in populations at high risk of MI.
The Rotterdam Study comprises a large and well-defined
study population. A great strength of the present study is that
severity of atherosclerosis was measured at multiple sites in
the arterial tree, making it possible to compare multiple
measures of atherosclerosis with regard to their predictive
value for MI within one study population. Nevertheless,
several methodological aspects of this study need to be
considered. Not all participants had complete data on all 4 of
the measures of atherosclerosis presented in the study. Al-
though we cannot exclude the possibility that health-related
issues have also played a role, missing data are predominantly
because of logistic reasons and are unlikely to have affected
our results. Furthermore, it would be interesting to see how
the hazard ratios for MI associated with measures of extracor-
onary atherosclerosis as reported in the present study relate to
those associated with coronary atherosclerosis. To date, no
prospective population-based data have yet been published on
coronary atherosclerosis and incident MI.
In conclusion, noninvasive measures of extracoronary
atherosclerosis are strong predictors of MI. The relatively
crude measures directly assessing plaques in the carotid
artery and abdominal aorta predict MI equally well as the
more precisely measured carotid IMT.
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